Zymewire
Zymewire is a vertical sales intelligence platform that helps biopharma service providers (CROs, CDMOs, CMOs, clinical research firms) identify stealth biotech companies, monitor sales signals, and access verified decision-maker contacts using human-verified AI and CRM integrations.
- Company typePrivate
- Founded2021
- HeadquartersToronto, Canada
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Zymewire does
Zymewire is a vertical sales intelligence platform purpose-built for biopharma service providers, including contract research organizations (CROs), contract development and manufacturing organizations (CDMOs/CMOs), and adjacent clinical research and pharma services firms. Its core product, the Zymewire Sales Intelligence Platform, identifies "stealth" biotech and pharma companies — often before they launch a public website — by ingesting company formation documents, grants, fundraising events, executive changes, preclinical research activity, and conference attendance signals. The platform segments target lists by more than 150 data points (therapeutic focus, drug delivery method, geographic region, cumulative funding, employee count, pipeline size) and provides verified decision-maker contact information for personalized outreach.
The underlying technology combines multiple third-party large language models (OpenAI, Anthropic, Google Gemini, accessed via OpenRouter) with an in-house human Data Team that verifies AI-extracted signals — a hybrid the company brands as "human-verified AI." Personalized feeds notify sales users when new matching signals are published. Native integrations with Salesforce (where Zymewire is an official AppExchange partner), Microsoft Dynamics, Copper, HubSpot, and Pipedrive embed the platform inside existing sales workflows.
Zymewire operates as a division of Lumerate Inc., headquartered in Toronto, Canada, with data hosted in the US, Canada, and EEA regions. The business runs on annual SaaS subscriptions sold through a sales-assisted enterprise motion with a free-trial entry point and quote-based pricing. It reports 400+ customers including Syneos Health, Evotec, Sartorius, Sterling Pharma Solutions, BioDuro, PCI, PharmSky, and RadMD, and is SOC 2 Type 2 compliant. The company appears privately held with no disclosed institutional funding beyond a 2017 Creative Destruction Lab accelerator placement.
Zymewire firmographics
Firmographics- Name
- Zymewire
- Legal name
- Lumerate Inc.
- Website
- https://welcome.zymewire.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Zymewire is a vertical sales intelligence platform that helps biopharma service providers (CROs, CDMOs, CMOs, clinical research firms) identify stealth biotech companies, monitor sales signals, and access verified decision-maker contacts using human-verified AI and CRM integrations.
- Ownership category
- akta.pro rank
Zymewire industry classification
Industry- Product category
- Sales Intelligence Software
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Wholesale-Computers & Peripheral Equipment & Software (5045)
- akta.pro primary industry
- CRM Data Quality, Enrichment & CDP-Adjacent CRM (HDAEAFAJ)
- akta.pro secondary industry
- Customer Engagement & Messaging (Email, SMS, Push, In-App) (BPAFAFAI)
Keywords
Where Zymewire is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Zymewire business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Revenue model
- SaaS Subscription: Sales Intelligence Management System sold as a subscription service to biopharma service providers. The platform provides ongoing access to sales intelligence data, stealth company identification, and contact verification services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Subscription-based SaaS with tiered access |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Zymewire product offering
Product offeringCore offering
Zymewire is a Sales Intelligence Management System for biopharma service providers (CROs, CMOs, CDMOs). It uses human-verified AI to scan thousands of documents daily, identify stealth biotech and pharma companies before public launch, surface real-time sales signals, segment targets across 150+ data points, and deliver verified decision-maker contacts and personalized feeds integrated with major CRMs.
Product overview
Zymewire is a unified Sales Intelligence Management System for biotech and pharma service providers. The core platform consists of several integrated modules: the Zymewire Sales Intelligence Platform serves as the central hub, combined with Stealth Company Discovery for identifying emerging companies before public launch, Sales Signal Feeds for real-time notifications, Company Segmentation for filtering targets by 120+ data points, Verified Contact Information for decision-maker outreach, and Account Monitoring for tracking existing clients. Zymewire University provides training on platform usage. The Professionals Database offers a directory of biotech/pharma professionals. The platform integrates with CRM systems including Salesforce, Microsoft Dynamics, Copper, HubSpot, and Pipedrive, and uses human-verified AI to scan documents and deliver actionable sales intelligence.
Differentiator
Problem solved
Functional benefit
Products and services
- Zymewire Sales Intelligence Platform A SaaS Sales Intelligence Management System for biotech and pharma service providers (CROs, CMOs, CDMOs) that identifies stealth companies, tracks sales signals, and delivers actionable leads through real-time updates, customizable feeds, and verified contact information. Integrates with Salesforce, Microsoft Dynamics, Copper, HubSpot, and Pipedrive.
- Stealth Company Discovery Identifies new biotech and pharma companies from company formation documents, grants, fundraising events, and early-stage research activities, often before they launch public websites. Designed for CROs, CDMOs and other biopharma service providers to prospect emerging companies.
- Sales Signal Feeds Personalized notification system delivering real-time updates on relevant signals including new preclinical research, executive changes, fundraising events, and conference attendance based on user-defined preferences and targeting criteria.
- Company Segmentation Allows users to segment company lists by over 150 data points including therapeutic focus, drug delivery method, geographic region, cumulative funding, employee count, and pipeline metrics to prioritize targets for sales outreach.
- Verified Contact Information Reveals verified contact information for decision-makers at biotech and pharma companies to enable personalized sales outreach by biopharma service providers.
- Account Monitoring
Quantifiable outcome
- Serving over 400 clients including the world's top CROs, CMOs and other service providers
- +1 more outcomes
Companies that use Zymewire
Customer profileNamed customers11 records
Segments3 records
Ideal customer profiles1 record
Zymewire technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability5 records
Feature5 records
Zymewire partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- SalesforcecoreOfficial Salesforce AppExchange partner. Zymewire integrates with Salesforce for CRM and sales data management. Users can sync pipeline data and integrate sales intelligence into their existing Salesforce workflows.
- OpenAIcoreSubprocessor providing AI-driven features and LLM processing for Zymewire's human-verified AI capabilities.
- Google LLCcoreSubprocessor providing cloud infrastructure (GCP), email services (Workspace), AI services (Gemini), and website analytics.
- CloudflarecoreContent Delivery Network (CDN), security services, and DDoS protection for Zymewire's platform.
- StripecorePayment processing, billing, and fraud prevention for subscription transactions.
- AnthropiccoreAI-driven features and LLM processing to support Zymewire's human-verified AI capabilities.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Zymewire competitors and assessment
Company assessmentBroad incumbents
- Crunchbase: Company intelligence platform covering funding events, founding signals, and growth indicators. Comparable on early-stage company detection and funding tracking, though broader in scope and not biopharma-specialized.
- ZoomInfo: Largest horizontal sales intelligence and contact data platform with significant coverage of biopharma accounts. Competes on breadth of company and contact data, intent signals, and CRM integrations, but lacks Zymewire's depth on stealth/preclinical biotech signals.
- PitchBook: Private and public company intelligence platform with strong biopharma coverage of financings, M&A, and company fundamentals. Comparable on the fundraising/signal dimension Zymewire highlights for stealth company detection.
- Citeline (Pharma Intelligence): Provider of clinical trial, drug development, and company intelligence for the biopharma industry. Larger incumbent with overlapping enterprise customers (CROs, CMOs), though positioned more for R&D and clinical operations than BD prospecting.
- LinkedIn Sales Navigator: LinkedIn's sales prospecting tool offering company and lead search, alerts, and CRM integrations. Used by many biopharma BD teams as an alternative or complement to vertical sales intelligence platforms.
Direct peers
- Definitive Healthcare: Healthcare-focused commercial intelligence platform serving biopharma and medtech companies with provider, disease, and contact data. Closest direct competitor to Zymewire's biopharma prospecting use case, with broader data but similar vertical specialization.
- Lusha: Contact and company data platform focused on simplifying B2B prospecting. Competes at the contact data layer of Zymewire's verified-contact offering, though without biopharma-specific signal coverage.
- SalesIntel: B2B sales intelligence platform offering human-verified contact data and company intelligence. Mirrors Zymewire's human-verification angle, though operating horizontally rather than vertically in biopharma.
- BioCentury: Long-standing biopharma intelligence publisher offering company, deal, and clinical pipeline data. Comparable to Zymewire in serving biopharma business development users, though oriented toward editorial intelligence versus Zymewire's automated signal feeds.
- Apollo.io: Sales intelligence and engagement platform combining B2B contact data with outreach sequencing. Overlaps with Zymewire on company/contact intelligence for sales prospecting, though focused horizontally rather than on biopharma verticals.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Zymewire social profiles
Digital presenceZymewire compliance and trust
Trust signalCompliance1 record
Zymewire financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zymewire leadership team
Management profileNumber of profiles
Profiles2 records
Zymewire funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zymewire M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zymewire
What does Zymewire do?
Zymewire is a Sales Intelligence Management System for biopharma service providers (CROs, CMOs, CDMOs). It uses human-verified AI to scan thousands of documents daily, identify stealth biotech and pharma companies before public launch, surface real-time sales signals, segment targets across 150+ data points, and deliver verified decision-maker contacts and personalized feeds integrated with major CRMs.
Is Zymewire a public or private company?
Zymewire is a private company. It is classified as corporate owned and is currently operating.
When was Zymewire founded?
Zymewire was founded in 2021. It employs 51 to 100 people.
Where is Zymewire based?
Zymewire is headquartered in Toronto, Canada, in the North America region.
How does Zymewire make money?
One revenue line is on record: saaS Subscription.
Who are Zymewire's main competitors?
Broad incumbents on record are Crunchbase, ZoomInfo, PitchBook, Citeline (Pharma Intelligence) and LinkedIn Sales Navigator. Direct peers are Definitive Healthcare, Lusha, SalesIntel, BioCentury and Apollo.io.
Does Zymewire have an API?
No public API is recorded for Zymewire.
What industry is Zymewire in?
Zymewire's product category is Sales Intelligence Software. Its primary akta.pro industry code is HDAEAFAJ, CRM Data Quality, Enrichment & CDP-Adjacent CRM, with a secondary code of BPAFAFAI, Customer Engagement & Messaging (Email, SMS, Push, In-App). Its NAICS code is 541714 and its SIC code is 5045.